Format
Sort by
Items per page

Send to

Choose Destination

Best matches for phytocannabinoids:

Molecular Pharmacology of Phytocannabinoids. Turner SE et al. Prog Chem Org Nat Prod. (2017)

Molecular Targets of the Phytocannabinoids: A Complex Picture. Morales P et al. Prog Chem Org Nat Prod. (2017)

Phytocannabinoids: a unified critical inventory. Hanuš LO et al. Nat Prod Rep. (2016)

Search results

Items: 1 to 20 of 247

1.

Cannabis Therapeutics and the Future of Neurology.

Russo EB.

Front Integr Neurosci. 2018 Oct 18;12:51. doi: 10.3389/fnint.2018.00051. eCollection 2018.

2.

A Survey of Cannabis Acute Effects and Withdrawal Symptoms: Differential Responses Across User Types and Age.

Sexton M, Cuttler C, Mischley LK.

J Altern Complement Med. 2018 Oct 31. doi: 10.1089/acm.2018.0319. [Epub ahead of print]

PMID:
30383388
3.

Regulatory Status of Cannabidiol in the United States: A Perspective.

Corroon J, Kight R.

Cannabis Cannabinoid Res. 2018 Sep 27;3(1):190-194. doi: 10.1089/can.2018.0030. eCollection 2018.

4.

New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders.

Scherma M, Masia P, Deidda M, Fratta W, Tanda G, Fadda P.

Medicines (Basel). 2018 Oct 2;5(4). pii: E107. doi: 10.3390/medicines5040107. Review.

5.

A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis.

Berman P, Futoran K, Lewitus GM, Mukha D, Benami M, Shlomi T, Meiri D.

Sci Rep. 2018 Sep 24;8(1):14280. doi: 10.1038/s41598-018-32651-4.

6.

Inhibitory effects of cannabidiol on voltage-dependent sodium currents.

Ghovanloo MR, Shuart NG, Mezeyova J, Dean RA, Ruben PC, Goodchild SJ.

J Biol Chem. 2018 Oct 26;293(43):16546-16558. doi: 10.1074/jbc.RA118.004929. Epub 2018 Sep 14.

7.

Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history.

Bonini SA, Premoli M, Tambaro S, Kumar A, Maccarinelli G, Memo M, Mastinu A.

J Ethnopharmacol. 2018 Dec 5;227:300-315. doi: 10.1016/j.jep.2018.09.004. Epub 2018 Sep 8. Review.

PMID:
30205181
8.

Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion.

Elliott MB, Ward SJ, Abood ME, Tuma RF, Jallo JI.

Concussion. 2017 Oct 4;2(4):CNC49. doi: 10.2217/cnc-2017-0010. eCollection 2017 Dec. Review.

9.

Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes.

Navarro G, Reyes-Resina I, Rivas-Santisteban R, Sánchez de Medina V, Morales P, Casano S, Ferreiro-Vera C, Lillo A, Aguinaga D, Jagerovic N, Nadal X, Franco R.

Biochem Pharmacol. 2018 Sep 6. pii: S0006-2952(18)30382-4. doi: 10.1016/j.bcp.2018.08.046. [Epub ahead of print]

PMID:
30194918
10.

Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches.

Bonn-Miller MO, ElSohly MA, Loflin MJE, Chandra S, Vandrey R.

Int Rev Psychiatry. 2018 Jun;30(3):277-284. doi: 10.1080/09540261.2018.1474730.

PMID:
30179534
11.

Cannabinoids in cancer treatment: Therapeutic potential and legislation.

Dariš B, Tancer Verboten M, Knez Ž, Ferk P.

Bosn J Basic Med Sci. 2018 Sep 2. doi: 10.17305/bjbms.2018.3532. [Epub ahead of print] Review.

12.

Δ9-tetrahydrocannabivarin impairs epithelial calcium transport through inhibition of TRPV5 and TRPV6.

Janssens A, Silvestri C, Martella A, Vanoevelen JM, Di Marzo V, Voets T.

Pharmacol Res. 2018 Oct;136:83-89. doi: 10.1016/j.phrs.2018.08.021. Epub 2018 Aug 28.

PMID:
30170189
13.

The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders.

Río CD, Millán E, García V, Appendino G, DeMesa J, Muñoz E.

Biochem Pharmacol. 2018 Aug 20. pii: S0006-2952(18)30348-4. doi: 10.1016/j.bcp.2018.08.022. [Epub ahead of print] Review.

PMID:
30138623
14.

Pharmacological treatment for REM sleep behavior disorder in Parkinson disease and related conditions: A scoping review.

de Almeida CMO, Pachito DV, Sobreira-Neto MA, Tumas V, Eckeli AL.

J Neurol Sci. 2018 Oct 15;393:63-68. doi: 10.1016/j.jns.2018.08.008. Epub 2018 Aug 10. Review.

PMID:
30118919
15.

Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis.

Rodríguez-Cueto C, Santos-García I, García-Toscano L, Espejo-Porras F, Bellido M, Fernández-Ruiz J, Muñoz E, de Lago E.

Biochem Pharmacol. 2018 Aug 1. pii: S0006-2952(18)30319-8. doi: 10.1016/j.bcp.2018.07.049. [Epub ahead of print]

PMID:
30076846
16.

Proteomics and Lipidomics in the Elucidation of Endocannabinoid Signaling in Healthy and Schizophrenia Brains.

Seabra G, Falvella ACB, Guest PC, Martins-de-Souza D, de Almeida V.

Proteomics. 2018 Sep;18(18):e1700270. doi: 10.1002/pmic.201700270. Epub 2018 Aug 20. Review.

PMID:
30070429
17.

Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome.

Vigli D, Cosentino L, Raggi C, Laviola G, Woolley-Roberts M, De Filippis B.

Neuropharmacology. 2018 Sep 15;140:121-129. doi: 10.1016/j.neuropharm.2018.07.029. Epub 2018 Jul 27.

PMID:
30056123
18.

Therapeutic applications of cannabinoids.

Maurya N, Velmurugan BK.

Chem Biol Interact. 2018 Sep 25;293:77-88. doi: 10.1016/j.cbi.2018.07.018. Epub 2018 Jul 21. Review.

PMID:
30040916
19.

A rapid method to determine nine natural cannabinoids in beverages and food derived from Cannabis sativa by liquid chromatography coupled to tandem mass spectrometry on a QTRAP 4000.

Di Marco Pisciottano I, Guadagnuolo G, Soprano V, De Crescenzo M, Gallo P.

Rapid Commun Mass Spectrom. 2018 Oct 15;32(19):1728-1736. doi: 10.1002/rcm.8242.

PMID:
30030940
20.

Chemical Profiling of Medical Cannabis Extracts.

Lewis MM, Yang Y, Wasilewski E, Clarke HA, Kotra LP.

ACS Omega. 2017 Sep 30;2(9):6091-6103. doi: 10.1021/acsomega.7b00996. Epub 2017 Sep 22.

Supplemental Content

Loading ...
Support Center